Episode

2404: MedPal AI Launches New Health — £1.3m Push Into GLP-1

Podcast
The Vox Markets Podcast
Published
May 21, 2026
Duration seconds
720
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8906249
Audio
https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8906249.mp3?modified=1779349881&sid=5051662&source=rss
JSON
/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2404-medpal-ai-launches-new-health-1-3m-push-into-glp-1
Markdown
/podcast/the-vox-markets-podcast-3914537/2404-medpal-ai-launches-new-health-1-3m-push-into-glp-1.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2404-medpal-ai-launches-new-health-1-3m-push-into-glp-1/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2404-medpal-ai-launches-new-health-1-3m-push-into-glp-1.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

MedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.